Target intelligence / Profile preview

Heme (iron–protoporphyrin IX complex) (None universally standardized; commonly referred to as "heme" (note: no authoritative single-letter or standard short-form abbreviation))

Target
None universally standardized; commonly referred to as "heme" (note: no authoritative single-letter or standard short-form abbreviation)
Molecular classification
Other (iron coordination complex / metallocofactor), Prosthetic group, Enzyme cofactor (component in multiple protein families, such as hemoproteins), Not a classical receptor, transporter, channel, or enzyme itself
01

Overview

Heme is a coordination complex of iron and protoporphyrin IX, essential as a prosthetic group in a variety of hemoproteins including hemoglobin, myoglobin, cytochromes, catalases, and peroxidases. It acts as a carrier for oxygen and electrons, enables redox catalysis, and serves as a chemical sensor in biological signal transduction pathways. Free and protein-bound heme is tightly regulated because unbound heme contributes to oxidative cellular damage and inflammation. Diseases of heme metabolism have widespread systemic effects, often impacting blood, liver, brain, and immune system function. “Heme/iron complex” is not a discrete therapeutic target but is critical for the function of many clinically relevant proteins and enzymes.

Other names
HemeHaem (British spelling)Iron–protoporphyrin IXFerroprotoporphyrin IXHemin (oxidized form)Hematin (hydroxy/ferric form)Iron–porphyrin complex
02

Mechanism of action

Direct binding to heme prosthetic group (e.g., antimalarial drugs, some enzyme inhibitors) - Chelation or sequestration of iron within heme (iron chelators) - Allosteric modulation of heme-protein interaction (rare, but possible for some effectors) - Enzyme inhibition or activation via heme binding, redox state manipulation, or modification of heme-dependent proteins - Scavenging of extracellular heme (e.g., haptoglobin/hemopexin therapies in development)

03

Biological functions

Oxygen transport (as part of hemoglobin and myoglobin)Electron transfer (as in cytochromes of the respiratory chain)Oxygen storage (myoglobin)Redox catalysis (found in catalases, peroxidases, cytochrome P450 enzymes)Signal transduction and cellular regulation (as a signaling ligand for certain proteins)Enzyme catalysis (cofactor for various enzymes such as cyclooxygenase, nitric oxide synthase)Gas sensing (nitric oxide, carbon monoxide, O₂)Maintenance of cellular redox state
04

Disease associations

Cancer (pro- and anti-tumor effects, oxidative stress involvement)Cardiovascular disease (oxidative damage, hemolysis-related pathology)Inflammation (extracellular heme is pro-inflammatory)Infection (iron acquisition is a driver of pathogenesis for microbes)Hemolytic anemias and porphyrias (heme metabolism disorders)Neurodegenerative disease (oxidative stress from free heme)Other
05

Safety considerations

Free heme is cytotoxic due to promotion of oxidative damage and inflammationIron overload conditions (e.g., hemochromatosis) cause tissue damageDrug interaction risk (e.g., drugs inhibiting heme-enzymes can cause adverse drug-drug interactions or toxic metabolite buildup)Risk of promoting microbial growth (because pathogens utilize iron from heme)
06

Interacting drugs

Hemin (used in acute porphyria treatment)

3 more in the full profile.

07

Biomarkers

Plasma free heme, hemopexin, and haptoglobin (for hemolysis/hemolytic anemia)Heme oxygenase-1 (HO-1) levels (as a marker of heme degradation and oxidative stress)Ferritin (reflecting iron metabolism, sometimes related to heme turnover)None specific to the heme/iron complex itself as a "target"

Beyond the preview

Go deeper on Heme (iron–protoporphyrin IX complex) (None universally standardized; commonly referred to as "heme" (note: no authoritative single-letter or standard short-form abbreviation)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heme (iron–protoporphyrin IX complex) (None universally standardized; commonly referred to as "heme" (note: no authoritative single-letter or standard short-form abbreviation)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call